Jafron Biomedical Co.,Ltd. (SHE:300529)
17.25
-0.48 (-2.71%)
Jun 4, 2026, 3:04 PM CST
Jafron Biomedical Company Description
Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide.
The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps.
The company was founded in 1989 and is based in Zhuhai, China.
Jafron Biomedical Co.,Ltd.
| Country | China |
| Founded | 1989 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,301 |
| CEO | Fan Dong |
Contact Details
Address: No. 98 Technology Six Road Zhuhai, 519085 China | |
| Phone | 86 75 6368 9708 |
| Website | jafroninternational.com |
Stock Details
| Ticker Symbol | 300529 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002995 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Fan Dong | Chairman of Board of Directors and GM |
| Xueyun Liao | Director and Financial Director |
| De Zhi Li | Vice President |
| Xian Min Tang | Vice President and Director |
| Feng Li | Vice President and Non-Independent Director |
| Aijun Wu | Vice President |
| Rui Wang | General Manager |
| Cong Huang | Board Secretary |